Cas:111454-67-2 6-iodo-8-chloroquinoline manufacturer & supplier

We serve Chemical Name:6-iodo-8-chloroquinoline CAS:111454-67-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-iodo-8-chloroquinoline

Chemical Name:6-iodo-8-chloroquinoline
CAS.NO:111454-67-2
Synonyms:6-iodo-8-chloroquinoline;8-Chloro-6-iodoquinoline;Quinoline, 8-chloro-6-iodo-
Molecular Formula:C9H5ClIN
Molecular Weight:289.500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:352.1±22.0 °C at 760 mmHg
Density:1.9±0.1 g/cm3
Index of Refraction:1.727
PSA:12.89000
Exact Mass:288.915497
LogP:2.93

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-iodo-8-chloroquinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Quinoline, 8-chloro-6-iodo- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-Chloro-6-iodoquinoline Use and application,8-Chloro-6-iodoquinoline technical grade,usp/ep/jp grade.


Related News: “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. ethyl (7-methoxy-1,2,3,4-tetrahydro-1-naphthalenylidene)acetate manufacturers Case in point: Hansoh Pharma is seeking approvals for its third-generation EGFR inhibitor Ameile (almonertinib) for newly diagnosed EGFR-mutated non-small cell lung cancer. (1S,3S,5S,8S,9S,10S,13R,14S,17R)-4,4,13,14-Tetramethyl-17-((1R,4S)-1,4,5-trimethyl-hexyl)-tetradecahydro-cyclopropa[9,10]cyclopenta[a]phenanthrene-1,3-diol suppliers IBI321 was discovered through a collaboration between Innovent and Eli Lilly and Company and has been developed in China by Innovent. The IND for IBI321 has been approved by the NMPA in China, and clinical trials in China are actively being conducted. Benzo[1,2-b:4,3-b’]dipyrrole-3(2H)-carboxamide,7-[[7-[[(1aS,9aS)-1a,2-dihydro-9-oxo-1H-benzo[f]cycloprop[c]indol-3(9H)-yl]carbonyl]-1,6-dihydrobenzo[1,2-b:4,3-b’]dipyrrol-3(2H)-yl]carbonyl]-1,6-dihydro- vendor & factory.